Japan's Brain/MINDS project held its first international symposium on January 29, 2019 at the University of Tokyo. With many national and transnational brain research projects nearing or having passed the five-year mark of operations, the symposium was an occasion to share achievements, forge collaborations and reflect on the future of 'big' neuroscience (Grillner et al., 2016) . Plenary speakers included representatives of the American BRAIN Initiative, the European Human Brain Project, the China Brain Project and the Allen Institute for Brain Science (Fig. 1) . As the Brain/MINDS project (Brain Mapping by Integrated Neurotechnologies for Disease Studies) uses the common marmoset as a model system, numerous workshop presentations focused on marmoset brain structure, function, development and engineering for disease modeling. This paper summarizes the proceedings of the symposium.
Opening remarks were delivered by Shigeo Okabe (University of Tokyo), the Brain/MINDS program supervisor, who noted that while progress in neuroscience has been rapid, it can still be further accelerated. One step in this direction is the International Brain Initiative formed by the various national brain projects. Bridging different domains and forging partnerships between academia and industry remain ongoing priorities.
Hideyuki Okano (Keio University and RIKEN Center for Brain Science) outlined the rationale for using the marmoset for brain mapping and disease modeling. Beyond the physiological and anatomical similarities with humans, genetic modification allows for the generation of diverse neurological disease models (Sasaki et al., 2009; Okano and Kishi, 2018) . The Brain/MINDS program has three arms -marmoset brain mapping, technology development and disease biomarker discovery -and has recently published the 3D atlas of the marmoset brain (Woodward et al., 2018) and an integrated neuro-histological pipeline for systematic mesoscale connectivity mapping in marmoset brains (Lin et al., 2019) . The methods employed address different levels of com-E-mail address: amanda.alvarez@riken.jp plexity and resolution and include functional imaging, local field potential measurement, intracellular recording, electrocorticography and calcium imaging. A new neuroimaging tool now in use is nVista, a microendoscope with a prism lens that allows for deep and multi-layer imaging (Kondo et al., 2018) . Future modifications will allow imaging subcortically in the basal ganglia, voltage imaging and pathway-specific imaging.
Transgenic marmoset lines created in Brain/MINDS mimic classic Parkinsonian symptoms, including early-stage sleep disorders and motor symptoms. Future studies of transgenic Parkinson's include elucidation of neural circuits, the role of protein accumulation, prediction of the onset of symptoms and drug development. Besides gene editing, Brain/MINDS is also exploring drug-induced or surgical interventions for the study of stroke and spinal cord injuries and lentiviral vector administration for Alzheimer's disease and other conditions.
Walter Koroshetz (National Institutes of Health) opened with the important public health challenge that motivates the US BRAIN Initiative. Neurological, mental, and substance abuse disorders are now the leading causes of disability in the developed world.
https://doi.org/10.1016/j.neures.2019.03.002 0168-0102/ The BRAIN Initiative approach is to map, measure, modulate and mathematically model the brain to uncover circuit structure and function. Launched in 2013, its first five years have primarily consisted of technology development, shifting towards technology utilization in discovery-driven neuroscience projects in the second five-year phase. High-priority research areas in the BRAIN Initiative are cell types, tools for circuit diagrams, technology to monitor neural activity, precise interventional tools, theory and data analysis tools, advancing human neuroscience, and integrative approaches.
To date, a flagship accomplishment of the NIH BRAIN Initiative has been high-throughput cell typing from the Cell Census Network. This project is working to classify all brain cell types in the mouse by cytoplasmic and nuclear RNA and aims to create reference brain cell atlases across diverse species. Another very recent development is the rapid and nanoscale-resolution imaging of entire fly and mouse brains by combining expansion microscopy and lattice light-sheet microscopy (Gao et al., 2019) . Uncovering neural information processing rules in the brain remains an underlying goal. Achieving that goal will require overcoming challenges in disparate techniques, scientific culture, infrastructure, and data sharing and standards. Interdisciplinary science and international collaboration are key solutions, says Koroshetz. A neuroethics subgroup is working with a newly convened BRAIN Initiative advisory group to ensure that neuroethical considerations are strongly integrated into the next phase of the Initiative.
Katrin Amunts (University of Düsseldorf) reported that the Human Brain Project (HBP) has reached its mid-point. The project is developing a European Research Infrastructure, EBRAINS, that offers services and tools to promote neuroscience, but also to translate knowledge from neuroscience into medicine, computing and new technologies (Amunts et al., 2016) . A unique part of the project is the Human Brain Atlas that includes multi-level and multimodal data on human brain organization. Cytoarchitecture is the interface through which the HBP is mapping brain data from all different scales, and this mapping is accelerated with the use of deep learning. Amunts remarked that atlasing can provide a link for collaboration and sharing data among the different brain initiatives. The HBP also relies heavily on supercomputing for high-throughput mapping, simulation and in silico drug design. A pan-European interactive computing infrastructure called Fenix is being established to allow open and efficient data sharing and collaboration. It allows researchers to analyze big data and to run computationallydemanding simulations.
Hongkui Zeng (Allen Institute for Brain Science) expanded further on the Cell Census Network, which is using approaches from the Allen Institute to profile cells across the mouse brain. The challenge of building a unified cortical cell type taxonomy comes from whether cells are defined by evolution, development or function (Zeng and Sanes, 2017) . The pipeline consists of single cell characterization at transcriptomic, physiological and morphological levels for both mouse and human. Transcriptomic types may be correlated with projection target specificity (Tasic et al., 2018) , and full neuron morphology reconstruction reveals further diversity (Gong et al., 2016) . The hierarchical order of cortical areas in the mouse has been revealed through molecular definitions and cell type-based projections. Cell types are key to discovering principles of brain organization.
The China Brain Project will launch in 2019, reported Mu-ming Poo (Chinese Academy of Sciences). Under the title "Brain science and brain-inspired technology", this project will include the mapping of mesoscopic macaque connectome and the generation of macaque models of brain disorders for early diagnosis and intervention. Further goals of the China Brain Project are training for sustainable research in primate biology and the study of higher cognitive function. In the latter area, mirror self-recognition in rhesus monkeys is an interesting finding (Chang et al., 2017) . Transgenic macaque monkeys exhibiting autism-like behaviors and macaque monkey clones with circadian disorder phenotypes have also been generated. Future efforts will focus on gene editing of stem cells and fibroblasts before somatic cell nuclear transfer, and gene editing of in vitro fertilized embryos to select for particular phenotypes and/or cloning of somatic cells.
Afternoon workshops focused on marmoset brain structure, function, developmental engineering and disease modeling. Marcello Rosa (Monash University) presented the Marmoset Brain Architecture Project (marmosetbrain.org), an open-access resource for visualization and analysis of cortico-cortical connections. Connectivity mapping can suffer when definitions of brain areas become disputed, and current methods for reporting and storing neuroanatomical data are lossy. The new project presented by Rosa contains full marmoset brain data sets that are threedimensionally registered to stereotaxic coordinates, facilitating future re-interpretation (Majka et al., 2016) . This resource will help bridge the gap between high-density cellular connectivity studies in smaller species like mice and non-invasive imaging data from humans.
Junichi Hata (RIKEN Center for Brain Science) discussed using magnetic resonance imaging for macro-level investigation of whole brain networks in marmoset. This method has been used for tractography, creating a neural structure connectome and in Parkinson's disease model studies. Shin Ishii (Kyoto University) meanwhile approaches macro-connectomics with diffusion tensor imaging and 2-photon tomography. A Bayesian tracker seeks optimal models of connected particles (Skibbe et al., 2019) and artificial intelligence performs automated annotation of images; this semi-supervised learning reduces the human effort involved in segmentation and data curation.
Mark Schnitzer (Stanford University) is known for developing miniature imaging devices and his talk focused on the technology pipeline for tracking neural ensemble dynamics. Implantable microendoscopes can now image cells in deep tissue with singlemicron resolution. These can be deployed to study behavior in wild-type and Parkinson's disease mice as well as in therapeutic interventions. Next developments in this area include a dual-arm microscope and voltage indicators for even finer-scale imaging.
Multiscale functional imaging of marmoset visual cortex was presented by Kenichi Ohki (University of Tokyo). This work accesses the hierarchy of areas, columns, neurons and synapses through wide-field calcium imaging in V1 and V2 cortices. Atsushi Miyawaki (RIKEN Center for Brain Science) discussed the applications of luminescent proteins developed in his lab. In vivo, long-term bioluminescent imaging is now possible thanks to the directed evolution of firefly luciferase for efficient catalysis of brighter synthetic compounds like AkaLumine-HCL (Iwano et al., 2018) . Erika Sasaki (Central Institute for Experimental Animals, Japan) discussed development of genetically modified nonhuman primate disease models. Different transgenic production methods have resulted in 13 kinds of genetically modified marmosets. Because of disadvantages with lentiviral vectors, the preferred method is now to use PiggyBac transposon vectors. Takafumi Minamimoto (National Institutes for Quantum and Radiological Science and Technology, Japan) presented the chemogenic toolbox for marmoset research. This includes PET imaging-guided chemogenetic manipulation of neural circuits in monkeys (Nagai et al., 2016) .
Finally, the tools of synaptic plasticity research are making their way from bench to bedside, says Takuya Takahashi (Yokohama City University), with PET probes to visualize AMPA receptors in the living human brain. In an ongoing clinical trial, patients with depression are observed to have fewer AMPA receptors. Takahashi suggests that many psychiatric disorders could be re-categorized as AMPA receptor disorders.
In closing, Hideyuki Okano remarked that all brain projects share the common targets of building neuroinformatics databases and large-scale simulation platforms. The integration of heterogeneous and multi-scale data, and ensuring data accessibility and re-use in particular, require robust synergistic platforms and to this end, international cooperation is paramount.
